Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
American Journal of Clinical Oncology
|
February 1, 1984
Large mediastinal mass in Hodgkin's disease. Results of two treatment modalities
G A Gomez, A M Panahon, L Stutzman, et al.
Medical and Pediatric Oncology
|
January 1, 1979
The incidence of post-splenectomy sepsis and herpes zoster in children and adolescents with Hodgkin disease
D M Green, L Stutzman, L E Blumenson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1986
Alternating cycles of combination chemotherapy for patients with recurrent Hodgkin's disease following radiotherapy. A prospectively randomized study by the Cancer and Leukemia Group B
V Vinciguerra, K J Propert, M Coleman, et al.
Cancer Clinical Trials
|
January 1, 1981
MER immunotherapy and combination chemotherapy for advanced, recurrent Hodgkin's disease. Cancer and Leukemia Group B study
V Vinciguerra, M Coleman, T F Pajak, et al.
Transfusion Medicine (Oxford, England)
|
October 18, 2002
Evaluation of the 3D BacT/ALERT automated culture system for the detection of microbial contamination of platelet concentrates
C P McDonald, A Rogers, M Cox, et al.
Cancer Treatment Reports
|
April 1, 1982
Chemotherapy and combined modality therapy for Hodgkin's disease: a progress report on Cancer and Leukemia Group B studies
C D Bloomfield, T F Pajak, A S Glicksman, et al.
Cancer
|
June 1, 1982
Effect of methanol extraction residue of Bacillus Calmette-Guerin in advanced Hodgkin's disease
M R Cooper, T F Pajak, N I Nissen, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG
|
August 18, 2025
Pediatric Pharmacy Association 2025 KIDs List of Key Potentially Inappropriate Drugs in Pediatrics
Christopher McPherson, Rachel S Meyers, Jennifer Thackray, et al.
Cancer
|
August 15, 1980
A new effective four-drug combination of CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) (NSC-79038), vinblastine, prednisone, and procarbazine for the treatment of advanced Hodgkin's disease
M R Cooper, T F Pajak, N I Nissen, et al.
Cancer
|
January 1, 1979
A comparative study of a BCNU containing 4-drug program versus MOPP versus 3-drug combinations in advanced Hodgkin's disease: a cooperative study by the Cancer and Leukemia Group B
N I Nissen, T F Pajak, O Glidewell, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
American Journal of Clinical Oncology
|
February 1, 1984
Large mediastinal mass in Hodgkin's disease. Results of two treatment modalities
G A Gomez, A M Panahon, L Stutzman, et al.
Medical and Pediatric Oncology
|
January 1, 1979
The incidence of post-splenectomy sepsis and herpes zoster in children and adolescents with Hodgkin disease
D M Green, L Stutzman, L E Blumenson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1986
Alternating cycles of combination chemotherapy for patients with recurrent Hodgkin's disease following radiotherapy. A prospectively randomized study by the Cancer and Leukemia Group B
V Vinciguerra, K J Propert, M Coleman, et al.
Cancer Clinical Trials
|
January 1, 1981
MER immunotherapy and combination chemotherapy for advanced, recurrent Hodgkin's disease. Cancer and Leukemia Group B study
V Vinciguerra, M Coleman, T F Pajak, et al.
Transfusion Medicine (Oxford, England)
|
October 18, 2002
Evaluation of the 3D BacT/ALERT automated culture system for the detection of microbial contamination of platelet concentrates
C P McDonald, A Rogers, M Cox, et al.
Cancer Treatment Reports
|
April 1, 1982
Chemotherapy and combined modality therapy for Hodgkin's disease: a progress report on Cancer and Leukemia Group B studies
C D Bloomfield, T F Pajak, A S Glicksman, et al.
Cancer
|
June 1, 1982
Effect of methanol extraction residue of Bacillus Calmette-Guerin in advanced Hodgkin's disease
M R Cooper, T F Pajak, N I Nissen, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG
|
August 18, 2025
Pediatric Pharmacy Association 2025 KIDs List of Key Potentially Inappropriate Drugs in Pediatrics
Christopher McPherson, Rachel S Meyers, Jennifer Thackray, et al.
Cancer
|
August 15, 1980
A new effective four-drug combination of CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) (NSC-79038), vinblastine, prednisone, and procarbazine for the treatment of advanced Hodgkin's disease
M R Cooper, T F Pajak, N I Nissen, et al.
Cancer
|
January 1, 1979
A comparative study of a BCNU containing 4-drug program versus MOPP versus 3-drug combinations in advanced Hodgkin's disease: a cooperative study by the Cancer and Leukemia Group B
N I Nissen, T F Pajak, O Glidewell, et al.
Page
of 7